Tuebingen, Germany

Thomas Bock Tuebingen


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Thomas Bock: Pioneering Advances in Antiviral Resistance Detection

Introduction

Thomas Bock, an esteemed inventor based in Tuebingen, Germany, has made significant contributions to the field of virology through his innovative research. He holds a pivotal patent that addresses crucial challenges in antiviral resistance, particularly concerning the hepatitis B virus.

Latest Patents

His noteworthy patent, titled "Detection and use of antiviral resistance mutations," focuses on viral variants that exhibit reduced sensitivity to specific agents and diminished interaction with immunological reagents. This invention emphasizes hepatitis B virus (HBV) variants that demonstrate complete or partial resistance to nucleoside or nucleotide analogs. It also explores the reduced responsiveness of these variants to antibodies targeting viral surface components. The implications of this patent extend to potential vaccines and diagnostic assays aimed at improving treatment options.

Career Highlights

Currently, Thomas Bock is associated with Abl Sa, a company known for its contributions to medical and technological advancements. His work exemplifies a commitment to addressing public health challenges through innovative scientific approaches and methodologies.

Collaborations

Throughout his career, Thomas has collaborated with notable colleagues, including Angeline Ingrid Bartholomeusz and Stephen Locarnini. These partnerships have fostered an environment of innovation and shared expertise, leading to impactful research outcomes in the field of antiviral strategies.

Conclusion

In summary, Thomas Bock's innovative efforts in the detection and utilization of antiviral resistance mutations represent a significant advancement in combating viral diseases. His patent not only enhances our understanding of hepatitis B virus resistance but also opens new avenues for developing effective vaccines and diagnostic tools. Thomas Bock continues to make strides in virology, marking his place as a key figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…